INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Biotech Delivers A Superior Patient And Site Experience
To become the sponsor of choice for sites and patients in congenital hyperinsulinism clinical trials, a small biotech company prioritized delivering a superior experience while streamlining operations.
-
Navigating Late-Phase Clinical Trial Enrollment: Strategies To Stay On Schedule
Late-phase trial delays cause massive revenue loss. This piece outlines AI pre-screening, direct-to-patient scaling, and retention tactics to hit study goals on time and ensure market readiness.
-
Productivity Hacks For An Effective RFP / Clinical Trial Vendor Selection
Starting a new clinical study requires careful vendor selection and these practical, actionable steps to enhance your selection process and ensure long-term partnership alignment.
-
Debunking 5 Misconceptions About Community-Based Research Sites
By confronting misconceptions about community-based research, we uncover evidence of how sites effectively manage complex trials while maintaining high standards of care.
-
Accelerating Parkinson's Disease Clinical Research Through Recruitment Capabilities1/14/2026
Centralized PD trials cut variability, speed enrollment, and enable genetic stratification, delivering high‑quality data and faster progress from early‑phase research to late‑stage development.
-
Accelerate Drug Development With Master Protocols5/15/2025
Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.
-
Use Case: A Patient-Centric Approach To Site Selection1/27/2025
Discover how Citeline’s robust datasets, combined with real-world data, inform intelligent site and investigator selection for a rare, autoimmune disease.
-
How Smarter Financial Strategies Improve Trial Performance3/10/2025
CROs play a critical role in ensuring the financial and operational success of clinical trials, yet outdated budgets and inefficient payment processes continue to create challenges for sites.
-
Five Ways Site-Facing Technology Helps Sponsors And CROs4/17/2025
Site-facing technology is presented as a crucial enabler of efficient trial execution, aligning site operations with sponsor timelines and objectives.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
With 80% of trials failing to enroll patients on time, improved collaboration between sites and sponsors is essential.
-
Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.
-
Hematology trials need strategies for complex endpoints, advanced therapies, and global compliance. Predictive analytics and tailored approaches accelerate timelines and optimize recruitment.
-
Enhance your Clinical Trial Payments solution with IQVIA Forecasting to leverage our global expertise and navigate the complexities of payments with ease.
-
Clinical trials must accommodate operational challenges and changes in the market, which includes a sponsor's ability to forecast site activation, monitor resources, and track competitive activity.